Thrombosis of mechanical tricuspid valve prosthesis: treatment by tissue-type plasminogen activator. Success after a 18 month-follow-up
Silva, A.; Jais, J.M.
Archives des Maladies du Coeur et des Vaisseaux 87(6): 813-817
1994
ISSN/ISBN: 0003-9683 PMID: 7702426 Document Number: 437916
Four years after a triple valve replacement, a 51 year old woman presented with signs of thrombosis of her tricuspid Saint Jude valve prosthesis, confirmed at echocardiography and fluoroscopy. Treatment with tissue-type plasminogen activator was completely successful with a result which was sustained at 18 months. A review of the literature confirms the superiority of thrombolytic therapy of first intention in the treatment of thrombosis of tricuspid mechanical prosthetic valves.
Document emailed within 1 workday
Related Documents
Rinaldi, J.P.; Yassine, M.; Aboujaoudé, F.; Belhakem, H.; Alsagheer, S.; Ben Ahmed, F.; Lemarié, P.; Boursier, M.; Khalifé, K. 1999: Successful thrombolysis on an aortic valve prosthesis by plasminogen tissue activator during pregnancy Archives des Maladies du Coeur et des Vaisseaux 92(4): 427-430Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Wu, J.-d.; Guan, H.; Wang, S.-h.; Liu, C.-w.; Jin, Y.-f.; Liu, B.; Ye, W.; Zeng, R. 2005: Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator Zhonghua Yi Xue Za Zhi 85(7): 491-492
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25
Harbeck, N.; Kates, R.E.; Look, M.P.; Meijer-Van Gelder, M.E.; Klijn, J.G.M.; Krüger, A.; Kiechle, M.; Jänicke, F.; Schmitt, M.; Foekens, J.A. 2002: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Research 62(16): 4617-4622
Higo, K.; Karasawa, A.; Kubo, K. 1991: Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)- ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate in a canine model of femoral thrombosis Arzneimittel-Forschung 41(12): 1251-1255
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Azzano, O.; French, P.; Robin, J.; Quinson, P.; de La Bourdonnaye, T.; Champsaur, G.; Mellier, G.; Normand, J.; Bozio, A. 1995: Thrombolytic therapy with rt-PA for thrombosis of tricuspid valve prosthesis during pregnancy Archives des Maladies du Coeur et des Vaisseaux 88(2): 267-270
Sueishi, K.; Nakashima, Y. 1987: Tissue-type plasminogen activator (t-PA) Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 70: 217-223
Turazza, F.M.; Pogna, M. 1990: Tissue-type plasminogen activator Medicina 10(1): 75-78
Fischer, B. 1990: Mechanisms of activation of tissue-type plasminogen activator Arzneimittel-Forschung 40(5): 625-632
Milligan, K.S. 1987: Tissue-type plasminogen activator: a new fibrinolytic agent Heart and Lung: the Journal of Critical Care 16(1): 69-74